{
    "2021-04-30": [
        [
            {
                "time": "2021-04-30",
                "original_text": "华大基因：和玉高林与高林同创持股比例降至5%以下",
                "features": {
                    "keywords": [
                        "华大基因",
                        "和玉高林",
                        "高林同创",
                        "持股比例",
                        "减持"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-04-30",
                "original_text": "华大基因(300676.SZ)股东深圳和玉高林等合计持股比例降至4.9999%",
                "features": {
                    "keywords": [
                        "华大基因",
                        "深圳和玉高林",
                        "持股比例",
                        "减持"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-04-30",
                "original_text": "华大基因：和玉高林和高林同创减持1734万股，不再是持股5%以上股东 减持股份",
                "features": {
                    "keywords": [
                        "华大基因",
                        "和玉高林",
                        "高林同创",
                        "减持",
                        "持股5%以上股东"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-04-30",
                "original_text": "深圳百亿富商汪建，“喜提”第二家上市公司",
                "features": {
                    "keywords": [
                        "汪建",
                        "华大基因",
                        "上市公司"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-04-30",
                "original_text": "顶流基金最新动向曝光：张坤看多苏泊尔 高瓴旗下私募新进伊利股份、华大基因、安图生物",
                "features": {
                    "keywords": [
                        "张坤",
                        "高瓴",
                        "华大基因",
                        "安图生物",
                        "伊利股份",
                        "苏泊尔",
                        "顶流基金"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "消费品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-30",
                "original_text": "上市公司战“疫”成绩单亮相，停摆行业有望显著改善",
                "features": {
                    "keywords": [
                        "上市公司",
                        "战疫",
                        "停摆行业",
                        "改善"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}